Welcome to proelbiotech.com
We are a company specialized in the production of in vitro medical devices.
Featured product
SARS-CoV-2 IgG antibody detection kit (ELISA)
This kit is intended for qualitative and quantitative detection of human IgG antibodies produced after SARS-CoV-2 infection or vaccination.
The kit is registered as a CE-marked in vitro diagnostics device with the Romanian authorities (reg. no. RO_IVD_357_859/10.11.2020).
- 100% specificity as determined by testing 88 samples collected prior February 2019
- 100% sensitivity as determined by testing 30 samples of recovered COVID-19 patients confirmed with positive RT-PCR and symptomatic contacts of these, all of which tested positive for SARS-CoV-2 IgG antibodies using a CE IVD marked chemiluminescent assay
- standard Elisa protocol, results in less than 2 hours
- suitable for automatic platforms
- extremely low background (the OD for negative samples is 0.038 ± 0.016)
- developed by a small but enthusiastic Romanian research group with vast experience in clinical diagnostics
Report on mRNA-vaccination induced antibody responses
Here we present the partial results of a study that aims to follow the kinetics of immune response due to vaccination with Comirnaty, an mRNA-based vaccine against COVID-19. The vaccine contains the genetic information necessary for synthesis of the SARS-CoV-2 spike protein. Immune response is directed against this protein, therefore IgG antibodies can be detected with diagnostic kits that contain the spike protein or its subunits (S1, S2, RBD). ...
About Proel Biotech
Proel Biotech SRL operates as a subsidiary of the Pro-Vitam Group, the products being developed following the results obtained by its research team. The Pro-Vitam laboratory can be distinguished from its competitors primarily by its internationally recognized research ...